Salvage brachytherapy for second ipsilateral breast tumor event: Relating dosimetric analysis to late side effects
Jean-Michel Hannoun-Levi
![Jean-Michel Hannoun-Levi]()
Jean-Michel Hannoun-Levi
Professor of Radiation Oncology Antoine Lacassagne Cancer Center - University C?te d’Azur
Second breast conservative treatement in 2nd ipsilateral breast cancer event has reassuring oncological outcomes and survival. The majority of patients did not experience significant late complications. Larger volume of CTV, in addition to larger absolute volumes of V100, V150 and V200 were associated with increased risk of late toxicity. Treatment plans with more needles and less DNR were as- sociated with less complications. https://authors.elsevier.com/a/1idkX5TpjqSgSl
CEO @ Immigrant Women In Business | Social Impact Innovator | Global Advocate for Women's Empowerment
6 个月???? ??? ?? ?? ???????? ??? ?????? ???? ?????? ???: ?????? ????? ??? ??????? ????? ????? ?????? ??????. https://chat.whatsapp.com/BubG8iFDe2bHHWkNYiboeU
Radiation Oncologist, and Researcher at AHN Cancer Institute. Professor and Interim Chair, Drexel University College of Medicine
1 年Excellent work!